期刊文献+

椎体成形术后应用唑来膦酸联合维生素K2治疗老年性椎体压缩骨折 被引量:11

Three-year clinical observation for treating aged vertebral compression fractures combined vertebral plasty with anti-osteoporotic drug
原文传递
导出
摘要 目的观察椎体成形术后应用唑来膦酸联合维生素K2治疗老年性椎体压缩性骨折的3年临床疗效。方法 2013年1月至2015年1月共收治老年性椎体压缩性骨折患者525例,其中女412例,男113例;年龄64~91岁,平均(79±11)岁。所有患者均予CT引导下椎体成形术手术治疗,术后2~4 d给予唑来膦酸静脉输注,同时补充维生素K2以及钙剂、维生素D。获得术前、术后1周和术后3年腰背痛视觉模拟评分(VAS)评分、Oswestry功能障碍指数(ODI),术前及术后3年骨密度、骨代谢指标的数据。采用配对样本t检验的方法对术后与术前,术后不同时间获得的各组数据进行统计分析。结果坚持1年随访为189(36%)人,2年随访为131(25%)人,坚持3年随访的患者为56(10.7%)人,56例中17例为发生再次椎体骨折。经3年随访,患者腰背痛VAS评分(t=3.01)、ODI评分(t=0.98)、骨密度同术前比较均有明显改善,且差异有统计学意义(P<0.05)。骨代谢指标中,骨钙素较术前明显提高(t=5.75),β-CTX较术前显著下降(t=3.06),差异有统计学意义(P<0.05),其他指标变化无统计学差异。结论老年性椎体压缩性骨折患者长期随访治疗的依从性不高。经过椎体成形术后联合多种抗骨质疏松药物3年的干预治疗,可以明显缓解患者临床症状、改善生活质量、促进骨形成、抑制骨吸收、提高骨密度。 Objective To observe the clinical curative effect of treatment for senile vertebral compression fractures by vertebral plasty combine with anti-osteoporosis drug for three years. Methods From January 2013 to January 2015,525 cases of aged vertebral compression fractures were observed,among which412 were females,113 were males; aged from 64 to 91 years,the average age was( 79 ± 11) years. All the patients accepted percutaneous vertebral plasty surgery guided by CT and C arm X ray,anti-osteoporotic drugs were administrated which included diphosphonate by intravenous infusion in postoperative 2 - 4 d,calcium,vitamin D and vitamin K2 supplements. The lower back pain visual analogue scale( VAS) and Oswestry disability index( ODI) were recorded preoperatively,one week postoperatively and at the last follow-up. Bone mineral density and bone metabolism index were recorded preoperatively and at the postoperative three-year follow-up. Paired t test was used to analyze the data of each group obtained at different time after the surgery and before the surgery. Results There were 189( 36%) patients came back for one year follow-up,131( 25%) for two-year follow-up,only 56 patients( 10. 7%) insisted three-year follow-up. Among these 56 patients,17 cases occurred vertebral fracture again. After three-year follow-up,the lower back pain VAS score( t = 3. 01), ODI score( t = 0. 98),bone mineral density improved compared with preoperative ones,and the differences were statistically significant( P 〈 0. 05). As for the bone metabolism index, the osteocalcin( OC) increased( t = 5. 75) and the β-CTX decreased( t = 3. 06) compared with preoperative ones,the differences were significant statistically( P 〈 0. 05),while the other indicators showed no statistical difference. Conclusions For the long-term follow-up,the treatment compliance of senile patients with vertebral compression fractures is not optimistic. After three-year treatment of vertebral plasty combined with anti-osteopo
作者 赵成毅 李青 梁道臣 张爱明 梅治 姚海燕 范志丹 陈应超 Zhao Chengyi;Li Qing;Liang Daochen;Zhang Aiming;Mei Zhi;Yao Haiyan;Fan Zhidan;Chen Yingchao(Zhong Shan City People' s Hospital,Spinal Surgery Department,Zhongshan 528400,China)
出处 《中华关节外科杂志(电子版)》 CAS 2018年第3期433-437,共5页 Chinese Journal of Joint Surgery(Electronic Edition)
关键词 骨质疏松 骨密度 药物疗法 骨质疏松性骨折 椎体成形术 Osteoporosis Bone density Drug therapy Osteoporotic fractures Vertebroplasty
  • 相关文献

参考文献12

二级参考文献103

  • 1杨惠林,顾晓晖,陈亮,陆俭,毛海青,孟斌,牛国旗,赵刘军,唐天驷.后凸成形术治疗骨质疏松性脊柱骨折的选择性与个体化[J].中国医学科学院学报,2005,27(2):174-178. 被引量:37
  • 2魏晟,聂绍发,朱桂宝,卢祖洵.成年人饮食行为评价量表的信度、效度分析[J].医学与社会,2006,19(7):20-23. 被引量:12
  • 3Wang G, Yang H, Chen K. Osteoporotic vertebral compression fractures with an intravertebral cleft treated by percutaneous balloon kyphoplasty[ J]. J Bone Joint Surg Br, 2010, 92:1553 - 1557. 被引量:1
  • 4Mao H, Zou J, Geng D, et al. Osteoporotic vertebral fractures without compression : key factors of diagnosis and initial outcome oftreatment with cement augmentation [ J ]. Neuroradiology, 2012, 54:1137 - 1143. 被引量:1
  • 5Black DM, Delmas PD, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis [ J ]. N Engl J Med, 2007, 356 : 1809 - 1822. 被引量:1
  • 6Black DM, Reid IR, Boonen S, et al. The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT) [ J]. J Bone Miner Res ,2012,27:243 - 254. 被引量:1
  • 7Black DM, Reid 1R, Cauley JA, et al. The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT) [ J]. J Bone Miner Res,2015,30:934 - 944. 被引量:1
  • 8Lyles KW, Col6n-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture[ J]. N Engl J Med ,2007,357 : 1799 - 1809. 被引量:1
  • 9Black DM, Schwartz AV, Ensrud KE, et al. Effects of continuing or stopping alendronate after 5 years of treatment : the Fracture Intervention Trial Long-term Extension ( FLEX ) : a randomized trial[ J]. JAMA,2006 ,296 :2927 - 2938. 被引量:1
  • 10Bone HG, Hosking D, Devogelaer JP, et al. Ten years' experience with alendronate for osteoporosis in postmenopausal women[J]. N Engl J Med ,2004,350 : 1189 - 1199. 被引量:1

共引文献370

同被引文献111

引证文献11

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部